Vulvar neoplasia in HIV positive women: a review.
Among genital malignancies, vulvar cancer and its precursor, Vulvar Intraepithelial Neoplasia (VIN), is less commonly encountered than cervical neoplasia. According to R.W. Jones (2001) vulvar cancer represents about 3-5% of all genital neoplasms and its peak of incidence is between 60 and 80 years of age. Risk factors for vulvar carcinoma are: smoking and immune depression, which expose to a higher risk of vulvar HPV infection caused by high risk strains. In recent years, increased prevalence and incidence of high grade VIN and vulvar invasive carcinoma in young patients (below 45 years of age) have been reported. The main group of affected cases is represented by HIV infected women. Data about the severity of immune depression, expressed by CD4 cell count, as an adjunctive risk factor for persistence, recurrence or progression, are conflicting and scanty. Moreover, information about the effect of Highly Active Antiretroviral Therapy (HAART) on the natural history of VIN are inconclusive. So far, a thorough examination of the vulvar region, associated with colposcopy and biopsy when indicated, should be considered a routine procedure in the gynaecological surveillance of HIV positive women.
Casolati
Elena
E
Department of Obstetrics and Gynaecology, Clinical Science Institute, L. Sacco Hospital, University of Milan, via GB Grassi 74, 20157 Milan, Italy. ecasolati@tin.it
Agarossi
Alberto
A
Valieri
Monica
M
Ferrazzi
Enrico
E
D023241:Antiretroviral Therapy, Highly Active; D002278:Carcinoma in Situ / Q000175:diagnosis* / Q000821:virology*; D005260:Female; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications*; D012307:Risk Factors; D014846:Vulvar Neoplasms / Q000175:diagnosis* / Q000821:virology*